Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
18
BRN Quote, Financials, Valuation and Earnings
Last price:
$1.50
Seasonality move
:
7.63%
Day range:
$1.45 - $1.53
52-week range:
$1.42 - $3.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.70x
P/B ratio:
1.17x
Volume:
8.7K
Avg. volume:
26K
1-year change:
-32.44%
Market cap:
$15.3M
Revenue:
$21.7M
EPS (TTM):
-$0.56
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.3M | $18.1M | $28.5M | $25.3M | $21.7M | |
| Revenue Growth (YoY) | 51.94% | -1.28% | 57.59% | -11.48% | -14.03% | |
| Cost of Revenues | $14.5M | $13.1M | $16.8M | $20.6M | $19.4M | |
| Gross Profit | $3.8M | $5M | $11.7M | $4.7M | $2.3M | |
| Gross Profit Margin | 20.91% | 27.82% | 41.12% | 18.64% | 10.52% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.8M | $7.1M | $8M | $7M | $5.6M | |
| Other Inc / (Exp) | -$2.7M | $9.6M | $2.8M | $1.4M | -$1.8M | |
| Operating Expenses | $5.8M | $7.1M | $8M | $7M | $5.6M | |
| Operating Income | -$2M | -$2M | $3.7M | -$2.2M | -$3.3M | |
| Net Interest Expenses | $3K | $13K | $1K | $2K | $2K | |
| EBT. Incl. Unusual Items | -$4.7M | $7.5M | $6.5M | -$864K | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3K | $332K | $347K | -$53K | $213K | |
| Net Income to Company | -$4.7M | $7.2M | $6.2M | -$811K | -$5.3M | |
| Minority Interest in Earnings | -$79K | -$950K | -$659K | -$150K | -$234K | |
| Net Income to Common Excl Extra Items | -$4.8M | $6.3M | $5.5M | -$961K | -$5.6M | |
| Basic EPS (Cont. Ops) | -$0.57 | $0.73 | $0.57 | -$0.10 | -$0.56 | |
| Diluted EPS (Cont. Ops) | -$0.57 | $0.73 | $0.57 | -$0.10 | -$0.56 | |
| Weighted Average Basic Share | $8.3M | $8.6M | $9.7M | $10M | $10M | |
| Weighted Average Diluted Share | $8.3M | $8.6M | $9.7M | $10M | $10M | |
| EBITDA | -$2.5M | $8.5M | $9.3M | $3.6M | -$10K | |
| EBIT | -$4.7M | $7.5M | $6.5M | -$862K | -$5.1M | |
| Revenue (Reported) | $18.3M | $18.1M | $28.5M | $25.3M | $21.7M | |
| Operating Income (Reported) | -$2M | -$2M | $3.7M | -$2.2M | -$3.3M | |
| Operating Income (Adjusted) | -$4.7M | $7.5M | $6.5M | -$862K | -$5.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9M | $4.6M | $8.4M | $6.8M | $4.3M | |
| Revenue Growth (YoY) | 58.66% | -6.43% | 81.71% | -18.37% | -37.64% | |
| Cost of Revenues | $3.6M | $3.8M | $5.7M | $5.6M | $4.2M | |
| Gross Profit | $1.3M | $788K | $2.7M | $1.2M | $58K | |
| Gross Profit Margin | 26.81% | 17.08% | 32.2% | 17.52% | 1.36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1M | $1.7M | $2.3M | $1.3M | $1.4M | |
| Other Inc / (Exp) | $481K | $2.7M | -$573K | $95K | -$536K | |
| Operating Expenses | $1M | $1.7M | $2.3M | $1.3M | $1.4M | |
| Operating Income | $277K | -$960K | $440K | -$130K | -$1.3M | |
| Net Interest Expenses | $2K | $7K | -- | $1K | -- | |
| EBT. Incl. Unusual Items | $756K | $1.7M | -$133K | -$36K | -$1.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29K | $44K | $22K | $34K | $26K | |
| Net Income to Company | $727K | $1.7M | -$155K | -$70K | -$1.9M | |
| Minority Interest in Earnings | -$99K | -$153K | $12K | -$26K | $2K | |
| Net Income to Common Excl Extra Items | $628K | $1.5M | -$143K | -$96K | -$1.9M | |
| Basic EPS (Cont. Ops) | $0.08 | $0.16 | -$0.02 | -$0.01 | -$0.19 | |
| Diluted EPS (Cont. Ops) | $0.08 | $0.16 | -$0.02 | -$0.01 | -$0.19 | |
| Weighted Average Basic Share | $8.3M | $9.4M | $10M | $10M | $10M | |
| Weighted Average Diluted Share | $8.3M | $9.4M | $10M | $10M | $10M | |
| EBITDA | $1M | $2M | $730K | $1.6M | -$978K | |
| EBIT | $758K | $1.8M | -$133K | -$35K | -$1.9M | |
| Revenue (Reported) | $4.9M | $4.6M | $8.4M | $6.8M | $4.3M | |
| Operating Income (Reported) | $277K | -$960K | $440K | -$130K | -$1.3M | |
| Operating Income (Adjusted) | $758K | $1.8M | -$133K | -$35K | -$1.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.3M | $18.1M | $28.5M | $25.3M | $21.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $14.5M | $13.1M | $16.8M | $20.6M | $19.4M | |
| Gross Profit | $3.8M | $5M | $11.7M | $4.7M | $2.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.8M | $7.1M | $8M | $7M | $5.6M | |
| Other Inc / (Exp) | -$2.7M | $9.6M | $2.8M | $1.4M | -$1.8M | |
| Operating Expenses | $5.8M | $7.1M | $8M | $7M | $5.6M | |
| Operating Income | -$2M | -$2M | $3.7M | -$2.2M | -$3.3M | |
| Net Interest Expenses | $3K | $13K | $1K | $2K | $2K | |
| EBT. Incl. Unusual Items | -$4.7M | $7.5M | $6.5M | -$864K | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3K | $332K | $347K | -$53K | $213K | |
| Net Income to Company | -$4.7M | $7.2M | $6.2M | -$811K | -$5.3M | |
| Minority Interest in Earnings | -$79K | -$950K | -$659K | -$150K | -$234K | |
| Net Income to Common Excl Extra Items | -$4.8M | $6.3M | $5.5M | -$961K | -$5.6M | |
| Basic EPS (Cont. Ops) | -$0.57 | $0.72 | $0.55 | -$0.09 | -$0.56 | |
| Diluted EPS (Cont. Ops) | -$0.57 | $0.72 | $0.55 | -$0.09 | -$0.56 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$2.5M | $8.5M | $6.3M | $3.6M | -$10K | |
| EBIT | -$4.7M | $7.5M | $3.6M | -$862K | -$5.1M | |
| Revenue (Reported) | $18.3M | $18.1M | $28.5M | $25.3M | $21.7M | |
| Operating Income (Reported) | -$2M | -$2M | $3.7M | -$2.2M | -$3.3M | |
| Operating Income (Adjusted) | -$4.7M | $7.5M | $3.6M | -$862K | -$5.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.1M | $28.5M | $25.3M | $21.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $13.1M | $16.8M | $20.6M | $19.4M | -- | |
| Gross Profit | $5M | $11.7M | $4.7M | $2.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.1M | $8M | $7M | $5.6M | -- | |
| Other Inc / (Exp) | $9.6M | $2.8M | $1.4M | -$1.8M | -- | |
| Operating Expenses | $7.1M | $8M | $7M | $5.6M | -- | |
| Operating Income | -$2M | $3.7M | -$2.2M | -$3.3M | -- | |
| Net Interest Expenses | $13K | $1K | $2K | $2K | -- | |
| EBT. Incl. Unusual Items | $7.5M | $6.5M | -$864K | -$5.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $332K | $347K | -$53K | $213K | -- | |
| Net Income to Company | $7.2M | $6.2M | -$811K | -$5.3M | -- | |
| Minority Interest in Earnings | -$950K | -$659K | -$150K | -$234K | -- | |
| Net Income to Common Excl Extra Items | $6.3M | $5.5M | -$961K | -$5.6M | -- | |
| Basic EPS (Cont. Ops) | $0.72 | $0.55 | -$0.09 | -$0.56 | -- | |
| Diluted EPS (Cont. Ops) | $0.72 | $0.55 | -$0.09 | -$0.56 | -- | |
| Weighted Average Basic Share | $34.4M | $38.9M | $39.9M | $40.1M | -- | |
| Weighted Average Diluted Share | $34.4M | $38.9M | $39.9M | $40.1M | -- | |
| EBITDA | $8.5M | $6.3M | $3.6M | -$10K | -- | |
| EBIT | $7.5M | $3.6M | -$862K | -$5.1M | -- | |
| Revenue (Reported) | $18.1M | $28.5M | $25.3M | $21.7M | -- | |
| Operating Income (Reported) | -$2M | $3.7M | -$2.2M | -$3.3M | -- | |
| Operating Income (Adjusted) | $7.5M | $3.6M | -$862K | -$5.1M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.2M | $3.1M | $4.4M | $3.2M | $2.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.6M | $2.5M | $2.9M | $3M | $1.5M | |
| Total Current Assets | $9.5M | $18M | $20.1M | $9.1M | $8.9M | |
| Property Plant And Equipment | $4M | $4.2M | $13.7M | $21.9M | $16.9M | |
| Long-Term Investments | $901K | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $15.2M | $24.4M | $37.2M | $35.4M | $30.7M | |
| Accounts Payable | $2.1M | $1.4M | $1.5M | $881K | $1.8M | |
| Accrued Expenses | $1.9M | $2.1M | $3.2M | $2.8M | $4.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.3M | $619K | $1.9M | $609K | $301K | |
| Total Current Liabilities | $6.4M | $5.9M | $8.9M | $6.6M | $7.8M | |
| Long-Term Debt | $58K | $47K | $44K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.1M | $14.9M | $18.1M | $16.7M | $17.6M | |
| Common Stock | $4.2M | $4.8M | $5.1M | $5.1M | $5.1M | |
| Other Common Equity Adj | -$1.4M | -- | -- | -- | -- | |
| Common Equity | -$2M | $9.5M | $19.1M | $18.7M | $13M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $92K | $8K | $20K | $13K | $22K | |
| Total Equity | -$2M | $9.5M | $19.2M | $18.8M | $13.1M | |
| Total Liabilities and Equity | $15.2M | $24.4M | $37.2M | $35.4M | $30.7M | |
| Cash and Short Terms | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Total Debt | $58K | $47K | $44K | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.2M | $3.1M | $4.4M | $3.2M | $2.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.6M | $2.5M | $2.9M | $3M | $1.5M | |
| Total Current Assets | $9.5M | $18M | $20.1M | $9.1M | $8.9M | |
| Property Plant And Equipment | $4M | $4.2M | $13.7M | $21.9M | $16.9M | |
| Long-Term Investments | $901K | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $15.2M | $24.4M | $37.2M | $35.4M | $30.7M | |
| Accounts Payable | $2.1M | $1.4M | $1.5M | $881K | $1.8M | |
| Accrued Expenses | $1.9M | $2.1M | $3.2M | $2.8M | $4.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.3M | $619K | $1.9M | $609K | $301K | |
| Total Current Liabilities | $6.4M | $5.9M | $8.9M | $6.6M | $7.8M | |
| Long-Term Debt | $58K | $47K | $44K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.1M | $14.9M | $18.1M | $16.7M | $17.6M | |
| Common Stock | $4.2M | $4.8M | $5.1M | $5.1M | $5.1M | |
| Other Common Equity Adj | -$1.4M | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $92K | $8K | $20K | $13K | $22K | |
| Total Equity | -$2M | $9.5M | $19.2M | $18.8M | $13.1M | |
| Total Liabilities and Equity | $15.2M | $24.4M | $37.2M | $35.4M | $30.7M | |
| Cash and Short Terms | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Total Debt | $58K | $47K | $44K | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.7M | $7.2M | $6.2M | -$811K | -$5.3M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $643K | $657K | $263K | $208K | |
| Change in Accounts Receivable | -$469K | -$357K | -$1.7M | $1.1M | $647K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $750K | $831K | $7.3M | $1.9M | $4.7M | |
| Capital Expenditures | $3.1M | $1.9M | $10.2M | $11.6M | $3.5M | |
| Cash Acquisitions | -- | $1.9M | -- | -- | -$185K | |
| Cash From Investing | -$833K | $3.7M | -$7.1M | -$11.2M | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$149K | -$599K | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $147K | $47K | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$30K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$87K | -$1M | -$647K | -$157K | -$226K | |
| Cash From Financing | $60K | $2.2M | $1.6M | -$786K | -$226K | |
| Beginning Cash (CF) | $4.6M | $4.6M | $11.3M | $12.8M | $2.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$23K | $6.7M | $1.7M | -$10M | $1.7M | |
| Ending Cash (CF) | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Levered Free Cash Flow | -$2.4M | -$1.1M | -$2.9M | -$9.7M | $1.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $727K | $1.7M | -$155K | -$70K | -$1.9M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $254K | $116K | $85K | $55K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $278K | -$1.3M | $1.6M | $1.8M | $1.2M | |
| Capital Expenditures | $307K | $654K | $2.1M | $1.3M | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $283K | $1.7M | -$1M | -$1.3M | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$149K | -$150K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$83K | -$18K | -$29K | -- | |
| Cash From Financing | -$87K | $1.4M | -$167K | -$209K | -- | |
| Beginning Cash (CF) | $4.1M | $9.5M | $12.6M | $2.6M | $4.4M | |
| Foreign Exchange Rate Adjustment | $4K | -$38K | -$176K | -$14K | $41K | |
| Additions / Reductions | $474K | $1.8M | $406K | $272K | $71K | |
| Ending Cash (CF) | $4.6M | $11.3M | $12.8M | $2.8M | $4.5M | |
| Levered Free Cash Flow | -$29K | -$1.9M | -$481K | $481K | $81K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.7M | $7.2M | $6.2M | -$811K | -$5.3M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $643K | $657K | $263K | $208K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $750K | $831K | $7.3M | $1.9M | $4.7M | |
| Capital Expenditures | $3.1M | $1.9M | $10.2M | $11.6M | $3.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -$185K | |
| Cash From Investing | -$833K | $3.7M | -$7.1M | -$11.2M | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$149K | -$599K | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $47K | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1M | -$647K | -$157K | -$226K | |
| Cash From Financing | $60K | $2.2M | $1.6M | -$786K | -$226K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$23K | $6.7M | $1.7M | -$10M | $1.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.4M | -$1.1M | -$2.9M | -$9.7M | $1.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2M | $6.2M | -$811K | -$5.3M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $643K | $657K | $263K | $208K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $831K | $7.3M | $1.9M | $4.7M | -- | |
| Capital Expenditures | $1.9M | $10.2M | $11.6M | $3.5M | -- | |
| Cash Acquisitions | -- | -- | -- | -$185K | -- | |
| Cash From Investing | $3.7M | -$7.1M | -$11.2M | -$2.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$149K | -$599K | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $47K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1M | -$647K | -$157K | -$226K | -- | |
| Cash From Financing | $2.2M | $1.6M | -$786K | -$226K | -- | |
| Beginning Cash (CF) | $23.8M | $45.6M | $27.9M | $14.1M | -- | |
| Foreign Exchange Rate Adjustment | -$14K | -$214K | $49K | $23K | -- | |
| Additions / Reductions | $6.7M | $1.7M | -$10M | $1.7M | -- | |
| Ending Cash (CF) | $30.5M | $47.1M | $17.9M | $15.8M | -- | |
| Levered Free Cash Flow | -$1.1M | -$2.9M | -$9.7M | $1.2M | -- | |
Get BRN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BRN
Sector
P/E ratio
--
10.16x
PEG ratio
-0.01x
0.02x
P/B ratio
1.17x
1.04x
Price / LTM sales
0.70x
0.92x
Growth Metrics
BRN
Sector
Revenue growth
-37.64%
-3.51%
Earnings growth
--
-5.45%
Revenue (5-year growth)
12.46%
7.23%
Earnings forecast
--
$0.26
Profitability
BRN
Sector
Profitability FY 2024
$2.3M
$145.2M
Return on invested capital
-34.19%
5.04%
Return on assets
-16.84%
3.75%
Return on equity
-34.19%
7.95%
Earnings Date
Last Earnings Date
Dec
16
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Mar
17
Balance Sheet
BRN
Sector
Total cash
$4.5M
$15M
Short term investments
--
$5.5M
Total assets
$30.7M
$442.9M
Long term debt
--
$122.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
